Brief: Perimeter Medical Imaging AI Receives U.S. FDA Breakthrough Device Designation For OCT
15/04/2021 13:35
April 15 (Reuters) - Perimeter Medical Imaging AI Inc
PINK.V :
* PERIMETER MEDICAL IMAGING AI RECEIVES U.S. FDA
BREAKTHROUGH
DEVICE DESIGNATION FOR ITS OPTICAL COHERENCE TOMOGRAPHY (OCT)
IMAGING SYSTEM WITH IMGASSIST AI
Source text for Eikon: ID:nBw1m5lgXa
Further company coverage: PINK.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Perimeter Medical Imaging AI
See all newsCanada's Perimeter Medical Imaging AI Q2 loss narrows on lower expenses
Perimeter Medical Imaging Q1 net loss narrows
Brief: Perimeter Medical Imaging Ai Closes First Tranche Of Non-Brokered Private Placement
Canada's Perimeter Medical Imaging prelim Q4 revenue jumps 143%
Brief: Perimeter Schedules Fourth Quarter And Full Year 2025 Financial Results Conference Call For March 31St Provides Corporate Update